OptiBiotix Health (LON:OPTI) Announces Earnings Results

OptiBiotix Health (LON:OPTI) released its earnings results on Thursday. The company reported GBX (1.52) earnings per share for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.

OptiBiotix Health Price Performance

OptiBiotix Health stock traded down GBX 0.61 during trading on Thursday, reaching GBX 5.99. 985,289 shares of the company were exchanged, compared to its average volume of 354,914. The stock’s 50 day simple moving average is GBX 5.80 and its two-hundred day simple moving average is GBX 5.74. The company has a market capitalization of £6.19 million, a P/E ratio of -1.56 and a beta of 1.82. OptiBiotix Health has a 52-week low of GBX 4.50 and a 52-week high of GBX 12.25.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.